Hunan Warrant Pharmaceutical Co. Ltd. A Cash Flow Reinvestment Rate
Hunan Warrant Pharmaceutical Co. Ltd. A cash flow reinvestment rate. Hunan Warrant Pharmaceutical Co. Ltd. A (688799) has a Cash Flow Reinvestment Rate of 4.17x as of December 2024, reinvesting CN¥592.69 Million (capex CN¥233.87 Million plus investments CN¥-358.82 Million) from operating cash flow of CN¥142.23 Million. See 688799 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hunan Warrant Pharmaceutical Co. Ltd. A (2019–2024)
Cash flow reinvestment rate of Hunan Warrant Pharmaceutical Co. Ltd. A from 2019 to 2024. Historical reinvestment intensity for Hunan Warrant Pharmaceutical Co. Ltd. A across 6 annual periods. Explore Hunan Warrant Pharmaceutical Co. Ltd. A cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Hunan Warrant Pharmaceutical Co. Ltd. A Cash Flow Reinvestment Rate by Year (2019–2024)
Hunan Warrant Pharmaceutical Co. Ltd. A cash flow reinvestment rate by year from 2019 to 2024. Year-by-year capital reinvestment analysis for Hunan Warrant Pharmaceutical Co. Ltd. A. For the full cash flow conversion analysis, see cash flow conversion of Hunan Warrant Pharmaceutical Co. Ltd. A.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.17x | CN¥592.69 Million | CN¥142.23 Million | CN¥233.87 Million | ▲ +516.8% |
| 2023 | 0.68x | CN¥144.89 Million | CN¥214.44 Million | CN¥105.76 Million | ▼ -71.0% |
| 2022 | 2.33x | CN¥362.47 Million | CN¥155.65 Million | CN¥131.85 Million | ▼ -56.2% |
| 2021 | 5.31x | CN¥609.40 Million | CN¥114.72 Million | CN¥92.10 Million | ▲ +383.9% |
| 2020 | 1.10x | CN¥114.89 Million | CN¥104.66 Million | CN¥53.75 Million | ▲ +158.5% |
| 2019 | 0.42x | CN¥49.55 Million | CN¥116.66 Million | CN¥24.34 Million | — |